Skip to main
ADHD
ADHD logo

Arcturus Therapeutics Ltd (ADHD)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy ADHD Stock

About Arcturus Therapeutics Ltd (ADHD)

The full company name is Arcturus Therapeutics Ltd.
Market cap$373.72M
Yesterday's volume224.46K
Revenue (TTM)
Avg. daily volume457.98K
EBITDA (TTM)
Open$13.67
Price / earnings ratio-5.46x
Yesterday's range$13.25 - $13.8
Debt / equity
52 week range$8.04 - $25.88
5 year debt / equity11.03x
Beta (LTM)1.45x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio
Ex-dividend date
Next earnings
Dividend payable date

Frequently Asked Questions (FAQ)

As of Jul 14, 2025, the market cap for ADHD stock is $373.73M

The current P/E ratio for ADHD stock is -5.46

The 52-week high for ADHD stock is $25.88. The current ADHD stock price $undefined is 100.00% below its 52-week high

The 52-week low for ADHD stock is $8.04. The current ADHD stock price $undefined has increased 100.00% from its 52-week low

No, the ADHD stock does not pay dividends to its shareholders

How to buy ADHD stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in ADHD stock

    Navigate to the Explore page. Then, type ADHD into the search bar. When you see ADHD stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased ADHD stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Buy ADHD Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.